Cite

HARVARD Citation

    Clavarezza, M. et al. (2013). Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study. Oncologist. pp. 924-925. [Online]. 
  
Back to record